AAAAAA

   
Results: 1-12 |
Results: 12
ROLE OF INTESTINAL P-GLYCOPROTEIN (MDR1) IN INTERPATIENT VARIATION INTHE ORAL BIOAVAILABILITY OF CYCLOSPORINE
Authors: LOWN KS MAYO RR LEICHTMAN AB HSIAO HL TURGEON DK SCHMIEDLINREN P BROWN MB GUO WS ROSSI SJ BENET LZ WATKINS PB
Citation: Ks. Lown et al., ROLE OF INTESTINAL P-GLYCOPROTEIN (MDR1) IN INTERPATIENT VARIATION INTHE ORAL BIOAVAILABILITY OF CYCLOSPORINE, Clinical pharmacology and therapeutics, 62(3), 1997, pp. 248-260
THE CAFFEINE BREATH TEST DOES NOT IDENTIFY PATIENTS SUSCEPTIBLE TO TACRINE HEPATOTOXICITY
Authors: FONTANA RJ TURGEON DK WOOLF TF KNAPP MJ FOSTER NL WATKINS PB
Citation: Rj. Fontana et al., THE CAFFEINE BREATH TEST DOES NOT IDENTIFY PATIENTS SUSCEPTIBLE TO TACRINE HEPATOTOXICITY, Hepatology, 23(6), 1996, pp. 1429-1435
EFFECT OF BISPHOSPHONATES AND GALLIUM ON DENTIN RESORPTION IN-VITRO
Authors: LIEWEHR FR CRAFT DW PRIMACK PD KULILD JC TURGEON DK SUTHERLAND DE SCHUSTER GS PASHLEY DH
Citation: Fr. Liewehr et al., EFFECT OF BISPHOSPHONATES AND GALLIUM ON DENTIN RESORPTION IN-VITRO, Endodontics & dental traumatology, 11(1), 1995, pp. 20-26
NOCTURNAL AUGMENTATION OF GROWTH-HORMONE (GH) SECRETION IS PRESERVED DURING REPETITIVE BOLUS ADMINISTRATION OF GH-RELEASING HORMONE - POTENTIAL INVOLVEMENT OF ENDOGENOUS SOMATOSTATIN - A CLINICAL RESEARCH-CENTER STUDY
Authors: JAFFE CA TURGEON DK FRIBERG RD WATKINS PB BARKAN AL
Citation: Ca. Jaffe et al., NOCTURNAL AUGMENTATION OF GROWTH-HORMONE (GH) SECRETION IS PRESERVED DURING REPETITIVE BOLUS ADMINISTRATION OF GH-RELEASING HORMONE - POTENTIAL INVOLVEMENT OF ENDOGENOUS SOMATOSTATIN - A CLINICAL RESEARCH-CENTER STUDY, The Journal of clinical endocrinology and metabolism, 80(11), 1995, pp. 3321-3326
SINGLE-DAY, DIVIDED-DOSE ORAL SODIUM-PHOSPHATE LAXATIVE VERSUS INTESTINAL LAVAGE AS PREPARATION FOR COLONOSCOPY - EFFICACY AND PATIENT TOLERANCE
Authors: HENDERSON JM BARNETT JL TURGEON DK ELTA GH BEHLER EM CRAUSE I NOSTRANT TT
Citation: Jm. Henderson et al., SINGLE-DAY, DIVIDED-DOSE ORAL SODIUM-PHOSPHATE LAXATIVE VERSUS INTESTINAL LAVAGE AS PREPARATION FOR COLONOSCOPY - EFFICACY AND PATIENT TOLERANCE, Gastrointestinal endoscopy, 42(3), 1995, pp. 238-243
INTERINDIVIDUAL VARIATION IN INTESTINAL MDR1 EXPRESSION - LACK OF SHORT-TERM DIET EFFECTS
Authors: LOWN KS FONTANA RJ SCHMIEDLINREN P TURGEON DK WATKINS PB
Citation: Ks. Lown et al., INTERINDIVIDUAL VARIATION IN INTESTINAL MDR1 EXPRESSION - LACK OF SHORT-TERM DIET EFFECTS, Gastroenterology, 108(4), 1995, pp. 737-737
THE ERYTHROMYCIN BREATH TEST PREDICTS THE CLEARANCE OF MIDAZOLAM
Authors: LOWN KS THUMMEL KE BENEDICT PE SHEN DD TURGEON DK BERENT S WATKINS PB
Citation: Ks. Lown et al., THE ERYTHROMYCIN BREATH TEST PREDICTS THE CLEARANCE OF MIDAZOLAM, Clinical pharmacology and therapeutics, 57(1), 1995, pp. 16-24
TACRINE HEPATOTOXICITY - THE USE OF CAFFEINE TO IDENTIFY POTENTIAL SUSCEPTIBILITY FACTORS
Authors: FONTANA RJ TURGEON DK WOOLF TF KNAPP MA WATKINS PB
Citation: Rj. Fontana et al., TACRINE HEPATOTOXICITY - THE USE OF CAFFEINE TO IDENTIFY POTENTIAL SUSCEPTIBILITY FACTORS, Hepatology, 19(4), 1994, pp. 90000063-90000063
PREDICTION OF INTERPATIENT AND INTRAPATIENT VARIATION IN OG-37-325 DOSING REQUIREMENTS BY THE ERYTHROMYCIN BREATH TEST - A PROSPECTIVE-STUDY IN RENAL-TRANSPLANT RECIPIENTS
Authors: TURGEON DK LEICHTMAN AB BLAKE DS SCHMOUDER RL LOWN KS ANNESLEY TM WATKINS PB
Citation: Dk. Turgeon et al., PREDICTION OF INTERPATIENT AND INTRAPATIENT VARIATION IN OG-37-325 DOSING REQUIREMENTS BY THE ERYTHROMYCIN BREATH TEST - A PROSPECTIVE-STUDY IN RENAL-TRANSPLANT RECIPIENTS, Transplantation, 57(12), 1994, pp. 1736-1741
TACRINE HEPATOTOXICITY - THE USE OF METABOLIC PROBES TO IDENTIFY POTENTIAL SUSCEPTIBILITY FACTORS
Authors: FONTANA RJ TURGEON DK WOOLF TF KNAPP MA WATKINS PB
Citation: Rj. Fontana et al., TACRINE HEPATOTOXICITY - THE USE OF METABOLIC PROBES TO IDENTIFY POTENTIAL SUSCEPTIBILITY FACTORS, Gastroenterology, 106(4), 1994, pp. 10000893-10000893
P450 3A ACTIVITY AND CYCLOSPORINE DOSING IN KIDNEY AND HEART-TRANSPLANT RECIPIENTS
Authors: TURGEON DK LEICHTMAN AB LOWN KS NORMOLLE DP DEEB GM MERION RM WATKINS PB
Citation: Dk. Turgeon et al., P450 3A ACTIVITY AND CYCLOSPORINE DOSING IN KIDNEY AND HEART-TRANSPLANT RECIPIENTS, Clinical pharmacology and therapeutics, 56(3), 1994, pp. 253-260
P450IIIA (CYP3A) ACTIVITY IN SEVERELY DEPRESSED-PATIENTS
Authors: WATKINS PB TURGEON DK GUTHRIE SK REMEN AL GRUNHAUS L
Citation: Pb. Watkins et al., P450IIIA (CYP3A) ACTIVITY IN SEVERELY DEPRESSED-PATIENTS, Journal of clinical psychopharmacology, 13(5), 1993, pp. 366-368
Risultati: 1-12 |